Get the Stockscreener App
5.22
2.97%
-0.16
Pre-market:
5.22
Candel Therapeutics Inc stock is traded at $5.22, with a volume of 517.96K.
It is down -2.97% in the last 24 hours and down -6.12% over the past month.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
See More
Previous Close:
$5.38
Open:
$5.35
24h Volume:
517.96K
Relative Volume:
0.69
Market Cap:
$286.55M
Revenue:
$124.00K
Net Income/Loss:
$-49.99M
P/E Ratio:
-3.0888
EPS:
-1.69
Net Cash Flow:
$-31.03M
1W Performance:
-3.33%
1M Performance:
-6.12%
6M Performance:
-1.14%
1Y Performance:
-1.14%
1-Day Range:
$5.19
$5.44
1-Week Range:
$5.19
$5.85
52-Week Range:
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
Name
Candel Therapeutics Inc
Sector
Industry
Phone
617-916-5445
Address
117 KENDRICK STREET, NEEDHAM
Compare CADL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.22 | 295.34M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-28-25 | Initiated | Stephens | Overweight |
| Sep-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-25 | Resumed | H.C. Wainwright | Buy |
| Feb-20-25 | Initiated | Citigroup | Buy |
| Feb-19-25 | Initiated | Canaccord Genuity | Buy |
| Feb-07-25 | Initiated | BofA Securities | Buy |
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Aug-23-21 | Initiated | Credit Suisse | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
| Aug-23-21 | Initiated | UBS | Buy |
View All
Candel Therapeutics Inc Stock (CADL) Latest News
Candel Therapeutics to present at Jefferies Global Healthcare Conference - Proactive financial news
Can volume confirm reversal in Candel Therapeutics Inc.CEO Change & Daily Entry Point Alerts - newser.com
What the charts say about Candel Therapeutics Inc. todayTrade Signal Summary & Capital Efficient Trading Techniques - newser.com
Will Candel Therapeutics Inc. stock reach all time highs in 20252025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
Can Candel Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Entry and Exit Point Strategies - newser.com
Candel Therapeutics, Inc. CEO Paul Peter Tak to Present at Jefferies Global Healthcare Conference 2025 - Quiver Quantitative
Nov 18: Candel Therapeutics (NASDAQ: CADL) to present at Jefferies Healthcare in London - Stock Titan
Will Candel Therapeutics Inc. see short term momentumJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
Is Candel Therapeutics Inc. building a consolidation baseJuly 2025 Market Mood & Weekly Momentum Picks - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stock2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
How Candel Therapeutics Inc. stock compares to growth peersJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
How Candel Therapeutics Inc. stock performs in stagflationAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
Intraday pattern recognizer results for Candel Therapeutics Inc.2025 Risk Factors & Daily Chart Pattern Signals - newser.com
What’s next for Candel Therapeutics Inc. stock priceOil Prices & Detailed Earnings Play Strategies - newser.com
Can Candel Therapeutics Inc. stock sustain revenue growth2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Why analysts upgrade Candel Therapeutics Inc. stockJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Will Candel Therapeutics Inc. stock outperform international peersMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Candel Therapeutics Inc. stock benefit from automationLong Setup & Real-Time Stock Entry Alerts - newser.com
Candel Therapeutics, Inc. (CADL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Candel Therapeutics, Inc. (CADL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Candel Therapeutics (NASDAQ:CADL) Rating Increased to Strong-Buy at Stephens - MarketBeat
Candel Therapeutics Inc Stock (CADL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):